Clinical Trial Update: Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance Imaging [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the utility of hyperpolarized 13C-pyruvate metabolic MRI for prostate cancer, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Hyperpolarized 13C-pyruvate (hyperpolarized 13C-labeled pyruvate)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Prostate Cancer | Phase 2 | Status: RECRUITING